These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1371801

  • 1. Immunohistochemical evaluation with Ki-67: an application to salivary gland tumours.
    Murakami M, Ohtani I, Hojo H, Wakasa H.
    J Laryngol Otol; 1992 Jan; 106(1):35-8. PubMed ID: 1371801
    [Abstract] [Full Text] [Related]

  • 2. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
    Alves FA, Pires FR, De Almeida OP, Lopes MA, Kowalski LP.
    Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
    [Abstract] [Full Text] [Related]

  • 3. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
    Pardis S, Zare R, Jaafari-Ashkavandi Z, Ashraf MJ, Khademi B.
    Turk Patoloji Derg; 2016 Sep; 32(1):15-21. PubMed ID: 26832177
    [Abstract] [Full Text] [Related]

  • 4. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
    Vargas PA, Cheng Y, Barrett AW, Craig GT, Speight PM.
    J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
    [Abstract] [Full Text] [Related]

  • 5. Kallikrein-related peptidase 10 expression in salivary gland tissues and tumours.
    Darling MR, Hashem NN, Zhang I, Mohamed AB, Fung K, Kwan K, Mara TW, Daley TD, Diamandis EP.
    Int J Biol Markers; 2012 Dec 27; 27(4):e381-8. PubMed ID: 23250777
    [Abstract] [Full Text] [Related]

  • 6. Immunoreactivity of proliferating cell nuclear antigen in salivary gland tumours: an assessment of growth potential.
    Yang L, Hashimura K, Qin C, Shrestha P, Sumitomo S, Mori M.
    Virchows Arch A Pathol Anat Histopathol; 1993 Dec 27; 422(6):481-6. PubMed ID: 8101406
    [Abstract] [Full Text] [Related]

  • 7. Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas.
    Maiorano E, Favia G, Pece S, Resta L, Maisonneuve P, Di Fiore PP, Capodiferro S, Urbani U, Viale G.
    Int J Immunopathol Pharmacol; 2007 Dec 27; 20(4):779-89. PubMed ID: 18179751
    [Abstract] [Full Text] [Related]

  • 8. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
    Shigeishi H, Yoneda S, Taki M, Nobumori T, Ohta K, Higashikawa K, Yasui W, Kamata N.
    Oncol Rep; 2006 Apr 27; 15(4):933-8. PubMed ID: 16525682
    [Abstract] [Full Text] [Related]

  • 9. Pleomorphic adenomas, adenoid cystic carcinomas and adenolymphomas of salivary glands analysed by a monoclonal antibody against myoepithelial/basal cells. An immunohistochemical study.
    Caselitz J, Osborn M, Hamper K, Wustrow J, Rauchfuss A, Weber K.
    Virchows Arch A Pathol Anat Histopathol; 1986 Apr 27; 409(6):805-16. PubMed ID: 2429435
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical study of the expression of fatty acid synthase and Ki-67 in salivary gland tumors.
    do Prado RF, da Silva Machado AL, Colombo CE, Carvalho YR.
    J Oral Pathol Med; 2011 Jul 27; 40(6):467-75. PubMed ID: 21385214
    [Abstract] [Full Text] [Related]

  • 11. Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas.
    Souza Freitas V, Dos Santos JN, de Andrade Santos PP, Nonaka CFW, Pereira Pinto L, de Souza LB.
    Eur Arch Otorhinolaryngol; 2018 Dec 27; 275(12):3075-3082. PubMed ID: 30361787
    [Abstract] [Full Text] [Related]

  • 12. [Quantitative study on nucleolar organizer regions in salivary gland tumours].
    Wang SZ.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Mar 27; 27(2):74-6, 127. PubMed ID: 1337733
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical features of lacrimal gland epithelial tumors.
    Mendoza PR, Jakobiec FA, Krane JF.
    Am J Ophthalmol; 2013 Dec 27; 156(6):1147-1158.e1. PubMed ID: 23972314
    [Abstract] [Full Text] [Related]

  • 14. Ki-67 and p53 immunostaining assessment of proliferative activity in salivary tumors.
    Faur AC, Sas I, Motoc AG, Cornianu M, Zamfir CL, Lazăr DC, Folescu R.
    Rom J Morphol Embryol; 2015 Dec 27; 56(4):1429-39. PubMed ID: 26743291
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical characterisation of extracellular matrix components of salivary gland tumours.
    Nara Y, Takeuchi J, Yoshida K, Fukatsu T, Nagasaka T, Kawaguchi T, Meng N, Kikuchi H, Nakashima N.
    Br J Cancer; 1991 Aug 27; 64(2):307-14. PubMed ID: 1909886
    [Abstract] [Full Text] [Related]

  • 16. Differential expression of topoisomerase IIalpha protein in salivary gland carcinomas: histogenetic and prognostic implications.
    Maruya S, Shirasaki T, Nagaki T, Kakehata S, Kurotaki H, Mizukami H, Shinkawa H.
    BMC Cancer; 2009 Feb 27; 9():72. PubMed ID: 19250538
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
    Andreadis D, Epivatianos A, Mireas G, Nomikos A, Poulopoulos A, Yiotakis J, Barbatis C.
    J Laryngol Otol; 2006 Apr 27; 120(4):298-304. PubMed ID: 16623973
    [Abstract] [Full Text] [Related]

  • 18. Migration-stimulating factor as a novel biomarker in salivary gland tumours.
    Aljorani LE, Bankfalvi A, Carey FA, Harada K, Ohe G, Jones SJ, Ellis IR, Schor SL, Schor AM.
    J Oral Pathol Med; 2011 Nov 27; 40(10):747-54. PubMed ID: 21481007
    [Abstract] [Full Text] [Related]

  • 19. Expression of c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study.
    Kernohan NM, Blessing K, King G, Corbett IP, Miller ID.
    J Pathol; 1991 Jan 27; 163(1):77-80. PubMed ID: 1672154
    [Abstract] [Full Text] [Related]

  • 20. [Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
    Zhang B, Lin J, Da J.
    Zhonghua Bing Li Xue Za Zhi; 2015 Jul 27; 44(7):499-503. PubMed ID: 26705042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.